Successful treatment of leptomeningeal disease in colorectal cancer with a regimen of bevacizumab, temozolomide, and irinotecan

J Clin Oncol. 2007 May 1;25(13):e14-6. doi: 10.1200/JCO.2006.10.3317.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Colorectal Neoplasms / complications
  • Colorectal Neoplasms / drug therapy*
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives
  • Humans
  • Irinotecan
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms / complications
  • Meningeal Neoplasms / drug therapy*
  • Meningeal Neoplasms / secondary
  • Middle Aged
  • Temozolomide
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Irinotecan
  • Dacarbazine
  • Camptothecin
  • Temozolomide